Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Telesta Therapeutics (Canada) | Researchclopedia

Back to institutions

Telesta Therapeutics (Canada)

Pointe-Claire, Quebeccompany

30

Works

8,043

Citations

43

h-index

Top Research Topics

DNA Repair Mechanisms PARP inhibition in cancer therapy Cell death mechanisms and regulation

Top Researchers

Liang Li Fudan University

1,303 works46,762 citationsh-index: 107

Recent Research

Ferroptosis-mediated Cell Death in Erythroblasts Treated with ATR Inhibitor Camonsertib (RP-3500)

Maayan Levy,Gino B. Ferraro,et al.

20260 citations

CRISPR and Genetic Engineering

Epigenetics and DNA Methylation

Cancer Genomics and Diagnostics

interferon and immune responses

Genomics and Chromatin Dynamics

Bladder and Urothelial Cancer Treatments

Microtubule and mitosis dynamics

BRCA gene mutations in cancer

Melanoma and MAPK Pathways

Stephen Morris Guy's and St Thomas' NHS Foundation Trust

861 works29,342 citationsh-index: 82

Richard P. Phipps Hypha Discovery (United Kingdom)

437 works22,173 citationsh-index: 81

Li Li Central South University

818 works20,850 citationsh-index: 69

María Koehler Pfizer (United States)

226 works11,332 citationsh-index: 34

Stephen J. Morris Telesta Therapeutics (Canada)

270 works9,378 citationsh-index: 49

CRISPR-enabled genetic screens identify synthetic lethal targets across frequently altered cancer drivers

Jessica Desjardins,Julian Bowlan,et al.

20260 citations

Anticipating on-target resistance to WRN inhibitors in microsatellite unstable cancers

Mark Orcholski,Nancy Laterreur,et al.

20260 citations

The PLK4 inhibitor RP-1664 demonstrates potent single-agent efficacy in neuroblastoma models through a dual mechanism of sensitivity

John M. Maris,Isabel Soria‐Bretones,et al.

20251 citations

Exceptional response to the ATR inhibitor, camonsertib, in a patient with ALT+ metastatic melanoma

Natalie Y.L. Ngoi,Ian M. Silverman,et al.

20253 citations

The cold immunological landscape of ATM-deficient cancers

S. K. Sinha,Victor Ng,et al.

20253 citations